Business ❯ Corporate Strategy

Market Expansion

International Markets International Business Product Development International Operations India Partnerships Acquisitions North America China Market Investment

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

The all-cash deal gives the Italian group a U.S. foothold to scale a Brain Health–focused rare-disease platform.

Stories older than 24h

Beyond Meat Shares Drop After Q2 Sales Outlook Misses Estimates

Insulet Beats Q1 Targets and Raises 2026 Outlook on Surging Omnipod Sales

Enlight Renewable Energy Posts Strong Q1 and Reaffirms 2026 Outlook as U.S. Becomes Top Market

Apple’s Eddy Cue Expects F1 Film Sequel, Eyes Expansion Beyond U.S. Rights

Dolby Meets Q2 Targets, Keeps Outlook as Vision and Atmos Expand

Cerus Raises 2026 Outlook After 24% Q1 Product Revenue Jump as INT200 Filing Nears

Coca‑Cola Posts Q1 Beat as FEMSA Feels Mexico Tax Squeeze

Netflix Sell-Off Seen as Buying Opportunity as New Formats Lift Engagement

AstraZeneca Tops Q1 Forecasts, Reaffirms 2026 Outlook as Oncology Fuels Growth

Rogo Raises $160 Million Series D Led by Kleiner Perkins to Scale AI Platform for Finance

Hyundai Glovis Puts Record 10,800‑Vehicle Carrier Into Service

Mercedes Unveils China-Only Long-Wheelbase Electric GLC With Six-Seat Option

Betterware de Mexico Expands Margins and Cuts Leverage in Q1 as Tupperware Latin America Deal Nears

Intuitive Surgical Posts Q1 Beat and Lifts Procedure Forecast

Sanrio Launches Sanrio Games, Unveils Switch Party Title for Fall 2026

Hardee’s Franchisee Enters Chapter 7 as Corporate Reopens 15 Locations

Tesla Rolls Out Driverless Robotaxis in Dallas and Houston With Tiny Fleets

CoreWeave Secures Megadeals, Lifts 2026 Sales Outlook to $12–$13 Billion

Datavault AI Activates First Edge GPU Sites in New York and Philadelphia